Trial intelligence / Profile preview

Triumeq observational study in adults with HIV infection and a history of injection drug use

2016-000087-42Phase 4Terminated

Sponsor
University College Dublin
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by University College Dublin. Primary endpoint: Tolerability. Started Feb 2016; status: terminated.

02

Drugs

abacavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2016-000087-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000087-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call